Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond
暂无分享,去创建一个
J. Ijzermans | N. Erler | D. Thorburn | H. Metselaar | F. Vondran | R. Romagnoli | A. Paul | R. Adam | J. Pirenne | B. Ericzon | V. Karam | P. Taimr | P. Nemec | W. Polak | S. Darwish Murad | T. Visseren | F. van der Heide
[1] K. Zieniewicz,et al. Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry , 2020, Transplantation.
[2] S. Alexopoulos,et al. Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database , 2020, Clinical transplantation.
[3] S. Vermeire,et al. Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis? , 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[4] J. Hodson,et al. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study , 2019, Journal of hepatology.
[5] Dimitris Rizopoulos,et al. JointAI: Joint Analysis and Imputation of Incomplete Data in R , 2019, J. Stat. Softw..
[6] P. Trivedi,et al. Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation , 2019, Alimentary pharmacology & therapeutics.
[7] K. Zieniewicz,et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation , 2018, Transplant international : official journal of the European Society for Organ Transplantation.
[8] E. Melum,et al. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[9] P. Trivedi,et al. The impact of ileal pouch‐anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis , 2018, Alimentary pharmacology & therapeutics.
[10] R. D. de Man,et al. Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list—a retrospective study , 2018, Transplant international : official journal of the European Society for Organ Transplantation.
[11] M. Bottai,et al. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study , 2018, Scandinavian journal of gastroenterology.
[12] T. Karlsen,et al. Primary sclerosing cholangitis - a comprehensive review. , 2017, Journal of hepatology.
[13] P. Trivedi,et al. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis. , 2017, Journal of hepatology.
[14] Dimitris Rizopoulos,et al. Bayesian imputation of time-varying covariates in linear mixed models , 2017, Statistical methods in medical research.
[15] S. Murad,et al. Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation. , 2017, Best practice & research. Clinical gastroenterology.
[16] B. Nemes,et al. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation , 2016, Expert review of gastroenterology & hepatology.
[17] N. Jamieson,et al. Influence of donor and recipient gender on liver transplantation outcomes in Europe , 2016, Liver international : official journal of the International Association for the Study of the Liver.
[18] M. Manns,et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] A. Burroughs,et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. , 2015, Journal of hepatology.
[20] F. Vleggaar,et al. Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis , 2013, Hepatology.
[21] C. Ponsioen,et al. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. , 2012, Journal of hepatology.
[22] Y. Nakanuma,et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] E. Björnsson,et al. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden , 2010, Hepatology.
[24] J. Neuberger,et al. Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry) , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[25] J. Neuberger,et al. A re‐evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] J. Trotter,et al. Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] M. Yeh,et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[28] T. Therneau,et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. , 2003, Gastroenterology.
[29] J. Pomposelli,et al. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. , 2003, Human pathology.
[30] L. Grande,et al. Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers , 2003, Transplantation.
[31] J. Reitsma,et al. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population , 2002, Gut.
[32] C. Benz,et al. [Primary sclerosing cholangitis]. , 2000, Der Internist.
[33] K. Batts,et al. Recurrence of primary sclerosing cholangitis following liver transplantation , 1999, Hepatology.
[34] R. Busuttil,et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. , 1997, Annals of surgery.
[35] G. Kootstra,et al. Categories of non-heart-beating donors. , 1995, Transplantation proceedings.
[36] P. Tandon,et al. The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience. , 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.